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ABSTRACT
INTRODUCTION
The elevation of serum  alanine  aminotranferase levels is associ-
ated most commonly with some forms of  liver diseases. The aim 
of this study was to determine the prevalence of elevated serum 
alanine aminotransferase levels and the possible liver damages 
in this region. 
This was a clinical laboratory  based study. The data was ob-
tained from the Danesh Medical Diagnostic Laboratory at Gor-
gan in northern Iran. The aminotransferase activity was mea-
sured by the pyridoxal -5-phsphate reaction. Values over 31 and 
41 U/L were considered as indicative of elevated enzyme activity 
in females and males respectively.
The findings of this study indicated that 16% of our population 
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in general and of those who were aged 18-40 years   in particu-
lar, had  a form of liver disorder due to elevated enzyme, with a 
higher incidence among the female  subjects, which seemed   to 
be slightly higher than that reported by other studies earlier. The 
incidence was slightly higher among females.
It seemed  that  high proportions of people (16%) in this region 
had  an elevated serum  enzyme activity of alanine  amino-
tranferase and according to well-documented reports, it might 
probably be associated with non-alcoholic  fatty liver disease. A 
comprehensive study is recommended to elaborate carefully the 
state of liver  diseases in this region of Iran.
Alanine transaminase(ALT) is an enzyme which is present mainly in 
the liver and  the status of this enzyme predicts the liver function. 
ALT is one- of the best markers whose levels can be evaluated to 
assess the liver damage, and the serum elevation of ALT is mostly 
clinically significant for the diagnosis of liver lesions such as hepatitis 
bile duct disorder. This enzyme is predominantly found in the liver 
and also the kidney, heart and pancreas contain smaller amounts 
of this enzyme, which is accompanied  by ALT elevation within the 
blood. Any damage to the liver is accompanied  by ALT elevation 
within the blood. Another enzyme, aspartate aminotransferase is 
usually simultaneously assessed, although the proper biochemical 
tests for the detection of liver damage include the evaluation of 
alkaline phosphatase lactate dehydrogenase (LDH) and bilirubin. 
Due to the high specificity of ALT, its serum activity is usually as-
sessed for the diagnosis of a wide variety of liver lesions, particu-
larly  cirrhosis and hepatitis.
In case of the serum elevation of bilirubin, the measurement of the 
ALT activity can help to diagnose whether the bilirubin elevation is 
due to  blood or  liver diseases. The determination of the ALT activ-
ity can also be used  to follow up any liver damage which can   oc-
cur   due to some medication which was prescribed by clinicians  in 
order to prevent  the artherosclerosis  which is caused by elevated 
cholesterol levels within the blood circulation.
Although ALT is a liver specific enzyme and  is well recommended, 
alkaline phosphatase and creatine kinase have to be measured to 
distinguish  liver cell damage versus biliary duct or myopathy  le-
sions. Liver damage and particularly, chronic liver damages such as 
fatty liver of non-alcoholic origin and viral hepatitis, occur in people 
all over the word [1].
The activity of serum ALT   is mostly measured to evaluate the liver 
damage [2], [3], although  liver biopsy is  an excellent method to 
diagnose the  liver damage confidently.  But, due to the invasive 
nature of this method, it cannot be used for a population based 
study and therefore, the serum ALT measurement can be a useful 
method to evaluate the liver damage [4]. On the basis  of the above 
facts, the present study was carried out at Gorgan in northern Iran 
to find out the prevalence of ALT elevation with the subsequent 
estimation of liver diseases in this region of Iran.
MATERIALS AND METHODS
The ALT data of the sample population for this present study were 
collected from patients who were referred to the Danesh Medi-
cal Diagnostic Laboratory at Gorgan  which is located in northern 
Iran. In this study, the data of 573 subjects, who were  referred to 
the above laboratory during one year (2009-10), was  obtained. 
On collecting the data   on  the serum ALT activity, each patient’s 
name was replaced with a code name to maintain the anonymity 
of the patients.  
ALT is a liver enzyme which is elevated  during the occurrence of 
liver lesions and is released into the blood circulation.     Its activ-
ity can subsequently be determined by laboratory methods. The 
determination the ALT activity in this study was based on IFCC 
without  the addition of pyridoxal-5-phosphate.  ALT catalyzes the 
following reaction:
L-Alanine+ 2-Oxyglutarate ---------- → L-Glutamate+Pyruvate 
which is a reversible reaction.
 
Pyruvate+ NADH+ H  ------- → L-Lactate + NAD
The reference ranges of ALT in this method were < 31U/L and<41 
U/L for females and males respectively and the ALT values   above 
these figures were considered as elevated ALT activity [5]. 
RESULTS
In this study, 93 persons (52 females and 41 males) out of 573 sub-
jects who were referred to the Danesh Medical Diagnostic Labora-
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and as   this study was not  a population –based study  and  as the 
elderly and children did not consist of a  large sample size, we can-
not argue for sure that  the liver disorder  was predominantly seen 
among the middle age group  of upto 40 years of age. This can be 
considered as a limitation of our study.
Considering the cost- effectiveness of any laboratory test, ALT  has 
been accepted  as the best single enzyme test for the prediction of 
liver damage and as  the first step of any multiple enzyme measure-
ment or other para- clinical tests [5]. It should be also mentioned 
that the ALT/AST ratio is a valuable index in the differential diagno-
sis of minor or sever chronic liver damage if the latter ratio is less 
than one or more than one respectively. There are many reports on 
the role of ALT in assessing  liver function  and  hence, the mea-
surement of ALT has been widely applied in the determination of 
fatty liver damages which are accompanied  by other disorders [6]. 
Although ALT measurement is commonly considered to be a  result 
of fatty liver damage, other organ abnormalities such as type-2 dia-
betes may also exist [7].
In the real  sense, it seems that the ALT/AST ratio which is widely 
used to evaluate the severity and prognosis of the damage which 
is done to the liver and the clinical utility of the ratio has extensively 
been studied [8], [9]. ALT elevation can most probably be associ-
ated with liver malfunction [13]. It seems that there  is some inter-
vention by some other factors such as insulin resistance and its 
related factors such as obesity and elevated triglycerides which can 
manipulate the usefulness of ALT elevation, in the clear cut diag-
nosis of liver damages. The non-alcoholic fatty liver seems to be at 
the top of the ALT elevation and it might be correlated with the latter 
disorder. The fatty liver itself can be caused by some metabolic dis-
orders which have been  mentioned earlier. Hepatitis is  the  other 
main cause of ALT elevation which  has been reported in some 
studies [1] and it seems that as it is an age related syndrome,  its 
prevalence has  increased with the chronological age [1], [10]. 
Due to some controversial reports about the role played by the 
serum ALT activity alone, there are studies suggesting that the 
confirmation of the ALT factor should be accompanied by molecu-
lar biological methods such as the PCR technique, particularly for 
hepatitis. There are also many reports indicating that serum ALT 
cannot be used in the diagnosis of hepatitis, but it seems that  it is 
an applicable method in studying fatty liver lesions [11], [12], [13], 
although there are some studies  which even  suggest that  the ALT 
elevation does not correlate with  fatty liver disease as  well [14].
CONCLUSION
The main concept behind this present study was to assess the 
prevalence of elevated ALT levels in this region, regardless of the 
type of liver disease. A comprehensive literature review about the 
role of ALT was present with controversial findings and at some 
point there are reports that are in agreement and those that are 
overlapping with the conclusions of one another.
From all these contradictory results and from our present study 
we can conclude that in northern Iran, the prevalence of serum 
ALT levels is about 16%, regardless of the origin of the disorder, 
which caused this elevation. On the basis of the acceptable facts 
in the literature, it can be suggested that the serum ALT  levels 
are usually elevated due to any liver damage, particularly non-al-
coholic fatty liver damage (NAFLD). Therefore, ALT determination 
is a single non-invasive laboratory test which gives its very first clue 
to the medical team to further examine the patients for other more 
specific medical and para-medical investigations for any liver dam-
age and particularly, NAFLD assessment.
In conclusion, according to our findings   that about 16% of our 
population might have a type of liver damage and considering the 
extensive report in this area of research, particularly NAFLD should 
carefully be investigated.
tory showed elevated ALT levels, which may have been associated 
with some sort of liver damage [4], although there  were contra-
dictory reports in this area of research.  The ALT elevation cannot 
be accepted universally as a marker for assessing liver damage. 
In this study, the patients were divided into 4 major groups. Out 
of 93 patients [5], [70], [13] and [5] subjects in the age groups of 
<18, 18-40, 40-65, >65 years had elevated ALT levels. The gender 
prevalence  among the various age groups were as follows (3,2), 
(29,41), (7,6)  and(2,3) males and females respectively. The lowest 
incidence of the ALT elevation was observed among the <18  and 
>65 year  age groups  (5%). The 18-40 years age group showed 
the highest prevalence (75%), which  was slightly higher among 
females than among the males (78% verses 70%). The age group 
of 40-65 years showed an elevated (14%) ALT prevalence. On the 
whole, a total of 93 out of 573 patients showed an elevated ALT 
prevalence (16%), which was slightly higher than that which was 
seen in some other studies [4].
The demographical characteristics of this part of Iran are as follows: 
This area  consists of  a cosmopolitan society of different races and 
ethnic groups. The diet mostly consists of fatty foods which are 
mainly fried  in cooking oils of an unsaturated nature and are baked 
in general, although in recent years, the unsaturated start  to have a 
good place but those of about 40 years of age already had enough 
fat. This is mainly an agricultural region and generally the level of 
education is good as a whole, but some people with higher educa-
tion also reside in this region. The men and women participate in 
sports, but it seems, most men they do the practice. This region 
is also located  at the south east of the Caspian sea, and consists 
of forests and agricultural lands and so, herbicides  are used there 
occasionally. [Table/Fig 1]
 Gender      Total No      Total No     Total No    Total No      Total
                  <18 years      18-40          40-65        >65
 Men       3(7%)        29(70%)      7(17%)        2(4%)          41(44%)
 Women       2(3%)        41(78%)      6(11%)        3(5%)          52(56%)
 Total Men,
 Women       5(5%)        70(75%)    13(14%)        5(5%)       93/573 (16%)
DISCUSSION
In our study, we also found that the ALT elevation correlated  with 
age, but not with the increasing chronological age among the mid-
dle age group of 18-40 years. We found that the prevalence of 
the ALT elevation was slightly higher among the female patients. In 
our study, we found that except for the <18 years age group, the 
prevalence of ALT was inversely correlated with the chronological 
age   as follows: 12%, 2.2% and 0.9% for the 18-40, 40-65, and 
>65 years age groups respectively.
We argue that it is advisable that the ALT measurement among the 
18-40 years age group should be followed by further careful para-
medical examinations to confirm the high prevalence of the ALT 
activity and its association with liver diseases.
ALT has been considered as a specific enzyme  which is related to 
liver disease. The simultaneous determination of ALT and asparate 
aminotransferase (AST) can be useful in the differential diagnosis 
of heart and muscle versus liver damages. Although ALT is a liver 
specific enzyme, it has been well recommended that alkaline phos-
phatase and creatine kinase  should also be measured to distin-
guish  liver cell damage versus biliary duct or myopathys lesions. 
Liver damage and particularly chronic liver damages such as fatty 
liver of non-alcoholic origin and viral hepatitis are involved in  people 
all over the word [1]. Our findings  from this study indicated that 
the ALT activity was most prominently elevated among the 18-40 
years age group. We also may simultaneously argue that perhaps 
this latter age group was most frequently visited by the clinicians. 
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[Table/Fig 1]: The prevalence of elevated ALT and possible liver disease at 
south –east Caspian Sea of northern Iran
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